backgroundtremend
progress
made
past
year
understand
role
play
immunophilin
particular
cyclophilin
support
replic
cycl
human
virus
grow
bodi
genet
biochem
evid
data
clinic
trial
confirm
cyclophilin
essenti
cofactor
contribut
establish
permiss
environ
within
host
cell
support
replic
hcv
cyclophilin
regul
replic
kinet
infect
modul
sensit
host
restrict
factor
cooper
transit
preintegr
complex
nucleu
infect
cell
cyclophilin
essenti
cofactor
whose
express
support
hcvspecif
rna
replic
human
hepatocyt
gener
significancepeptidylprolyl
isomeras
inhibitor
use
clinic
trial
valid
cyclophilin
antivir
target
treatment
chronic
hepat
c
viru
infect
molecular
probe
identifi
role
play
immunophilin
support
replic
cycl
human
virus
scope
reviewthi
review
summar
emerg
research
defin
function
immunophilin
support
replic
cycl
hcv
hbv
coronavirus
viral
pathogen
describ
new
inform
suggest
role
immunophilin
regul
innat
immun
respons
chronic
viral
infect
major
conclusionsth
depend
cyclophilin
evolutionarili
distinct
virus
accomplish
variou
step
replic
viral
entri
initi
genom
nucleic
acid
replic
viral
genom
uncoat
nuclear
import
nuclear
entri
emphas
potenti
cyclophilin
inhibitor
therapeut
agent
regulatori
approv
cyclosporin
neoral
sandimmun
gengraf
tacrolimu
prograf
advagraf
unquestion
revolution
field
solid
organ
tissu
transplant
elucid
biolog
target
mechanismsofact
cyclosporin
led
directli
discoveri
two
multienzym
famili
exhibit
uniqu
catalyt
activ
cyclophilin
fk
bind
protein
share
littl
sequenc
homolog
howev
capabl
catalyz
interconvers
two
energet
prefer
conform
ci
tran
planar
peptid
bond
preced
intern
prolin
residu
famili
enzym
refer
peptidyl
prolyl
cistran
isomeras
ppias
catalyz
revers
peptid
bond
isomer
noncoval
reaction
requir
consumpt
atp
rather
depend
energi
deriv
protein
substrat
collect
cyclophilin
fk
bind
protein
refer
immunophilin
virtu
abil
bind
highli
immunosuppress
agent
contrast
third
recent
discov
class
human
ppias
enzym
parvulin
sensit
inhibit
either
cyclosporin
parvulin
origin
describ
novel
ppias
activ
isol
escherichia
coli
shown
present
higher
organ
sequenc
homolog
yeast
protein
ess
lead
turn
identif
ppias
correspond
human
ortholog
pin
identifi
twohybrid
assay
protein
interact
nima
later
confirm
ppias
abil
complement
yeast
ess
delet
mutant
unlik
cyclophilin
fk
bind
protein
present
human
genom
multigen
famili
express
multipl
isoform
parvulintyp
ppias
express
two
human
gene
immunophilin
parvulin
ubiquit
distribut
throughout
natur
identifi
organ
examin
date
includ
bacteria
fungi
anim
plant
cyclosporin
suppress
immun
function
bind
respect
intracellular
target
cyclophilin
fk
bind
protein
fkbp
remark
exampl
converg
evolut
binari
complex
form
cyclosporin
cyclophilin
form
high
affin
ternari
complex
calcineurin
ternari
complex
block
intrins
phosphatas
activ
calcineurin
turn
inhibit
dephosphoryl
driven
nuclear
transloc
member
nuclear
factor
activ
tcell
nfat
famili
transcript
factor
inhibit
nuclear
transloc
nfat
reduc
express
mani
lymphokin
includ
requir
bcell
help
requir
tcell
expans
prolifer
profound
immunosuppress
activ
exert
cyclosporin
provid
rational
investig
use
agent
wide
varieti
condit
character
uncontrol
hyperinflammatori
respons
includ
autoimmun
diseas
muscular
dystrophi
crohn
diseas
rheumatoid
arthriti
ischem
reperfus
injuri
follow
myocardi
infarct
stroke
ocular
diseas
uveiti
xerophthalmia
dermatolog
condit
atop
dermat
sever
recalcitr
plaqu
type
psoriasi
gener
therapeut
effect
cyclosporin
use
primari
indic
prevent
allograft
reject
secondari
indic
atop
dermat
xeropthalmia
well
investig
use
attribut
abil
bind
cognat
immunophilin
inhibit
calcineurin
phosphatas
activ
although
varieti
method
develop
recent
year
measur
protein
bind
prolin
rich
region
includ
yeast
two
hybrid
analysi
gst
pull
fluoresc
anisotropi
circular
dichroism
nuclear
magnet
reson
techniqu
limit
success
identifi
addit
bind
target
therefor
role
play
immunophilin
pathophysiolog
hyperinflammatori
autoimmun
condit
natur
substrat
ppias
difficult
imposs
identifi
typic
exhibit
bind
constant
micromolar
rang
easili
escap
detect
proteinbas
captur
techniqu
quantit
character
isomer
nativ
protein
repres
second
major
difficulti
success
appli
highli
stabl
protein
rnase
bovin
pancreat
trypsin
inhibitor
assay
method
therefor
reli
measur
prolin
isomer
nonphysiolog
substrat
compris
short
chemic
modifi
peptid
ppias
catalyz
forward
revers
isomer
reaction
proteas
coupl
techniqu
employ
trap
reaction
product
order
assess
unidirect
catalysi
contrast
autoimmun
diseas
hyperinflammatori
condit
tremend
progress
made
past
year
understand
role
play
immnophilin
particular
cyclophilin
support
replic
cycl
human
virus
grow
bodi
genet
biochem
evid
data
clinic
trial
confirm
cyclophilin
essenti
host
cofactor
contribut
establish
permiss
environ
within
host
cell
support
infect
replic
hcv
pull
experi
use
identifi
specif
cyclophilin
bind
protein
virus
includ
capsid
protein
express
nonstructur
protein
express
hcv
rel
greater
bind
affin
demonstr
virallyencod
protein
almost
certainli
reflect
evolutionari
select
advantag
part
pathogen
allow
outcompet
host
recruit
critic
protein
extent
observ
constitut
indirect
evid
cyclophilin
inde
essenti
cofactor
necessari
support
viral
replic
clinic
proof
concept
demonstr
use
secondgener
nonimmuno
suppress
analog
cyclosporin
confirm
cyclophilin
valid
biochem
target
develop
therapeut
treat
patient
chronic
infect
either
hcv
base
part
result
sensit
cyclosporin
vitro
use
surrog
marker
infer
cyclophilin
play
oblig
role
support
viral
replic
vitro
sensit
cyclosporin
observ
hbv
coronavirus
influenza
cytomegaloviru
human
papilloma
viru
review
focu
summar
bodi
research
establish
role
play
immunophilin
support
hcv
infect
replic
addit
emerg
data
describ
potenti
role
play
immunophilin
support
replic
human
virus
discuss
togeth
new
inform
suggest
immunophilin
may
play
role
regul
innat
immun
respons
chronic
viral
infect
pathogenesi
infect
poorli
understood
suggest
aid
character
phase
diseas
progress
wherebi
variou
type
activ
lymphocyt
particip
destruct
healthi
well
infect
cell
draw
analog
chronic
infect
autoimmun
cytopenia
aplast
anemia
concept
diseas
progress
led
mani
specul
loss
lymphocyt
infect
individu
could
mitig
treatment
immunosuppress
therapi
recent
success
cyclosporin
prevent
allograft
reject
larg
attribut
abil
inhibit
depend
tcell
activ
prolifer
step
also
recogn
import
aspect
replic
observ
prompt
pilot
evalu
cyclosporin
patient
advanc
relat
diseas
eight
patient
evid
either
pneumocysti
carinii
pneumonia
kaposi
sarcoma
receiv
cyclosporin
total
daili
dose
mgkg
given
divid
dose
everi
hour
dose
adjust
order
maintain
trough
plasma
concentr
ngml
typic
regimen
transplant
recipi
upon
initi
cyclosporin
treatment
patient
exhibit
clinic
sign
nausea
vomit
fatigu
laboratori
evid
declin
lymphocyt
platelet
acceler
diseas
progress
paradox
treatment
cyclosporin
increas
effici
viru
isol
patient
cessat
treatment
led
resolut
exacerb
symptom
research
conclud
cyclosporinebas
immunosuppress
therapi
aid
patient
warrant
nonetheless
work
provid
impetu
evalu
use
cyclosporin
mechanist
probe
role
cyclophilin
infect
replic
initi
report
vitro
antivir
activ
cyclosporin
describ
abil
compound
decreas
product
infecti
chronic
infect
cell
howev
mechanist
data
accompani
report
although
inhibit
ppias
activ
cyclophilin
fkbp
could
exclud
account
observ
antivir
effect
specul
tcell
activ
calcineurin
nfat
pathway
could
potenti
exploit
target
discoveri
therapeut
applic
yeast
twohybrid
techniqu
reveal
two
host
protein
cyclophilin
b
bound
specif
gag
polyprotein
gag
albeit
differ
affin
result
confirm
use
gstcyclophilin
fusion
construct
bind
gag
capsid
cyclophilin
b
inhibit
cyclosporin
suggest
ppias
activ
site
immunophilin
involv
bind
viral
protein
abil
gstcyclophilin
fusion
construct
captur
calcineurin
depend
presenc
cyclosporin
howev
construct
capabl
bind
gag
provid
first
indirect
evid
antivir
activ
cyclosporin
could
manifest
without
involv
calcineurin
cyclophilindepend
pathway
author
state
independ
antivir
effect
calcineurin
nfat
pathway
could
address
use
meala
csa
analog
bind
cyclophilin
suppress
tcell
activ
use
gstcyp
fusion
construct
express
vector
contain
gag
analysi
purifi
virion
demonstr
cyclophilin
immunophilin
specif
incorpor
virion
evid
found
incorpor
cyclophilin
b
virion
virion
produc
clone
siv
provirus
incorpor
cyclophilin
consist
specif
gag
protein
speci
bind
cyclophilin
vitro
accordingli
cyclosporin
inhibit
replic
virus
cyclophilin
bind
within
gag
local
prolin
rich
region
within
identifi
critic
residu
virus
harbor
substitut
incorpor
cyclophilin
exhibit
decreas
replic
indic
infect
requir
format
gagcyclophilin
complex
report
antivir
activ
analog
cyclosporin
retain
cyclophilin
bind
form
ternari
immunosuppress
complex
calcineurin
confirm
immunosuppress
tcell
activ
pathway
account
activ
cyclosporin
analog
inhibit
enzymat
activ
nonstructur
protein
includ
revers
transcriptas
integras
proteas
inhibit
interact
rev
rev
respons
element
infer
cyclophilin
like
involv
earli
step
viral
replic
cycl
occur
immedi
post
entri
studi
also
demonstr
exert
activ
confirm
fk
bind
protein
involv
replic
cyclophilin
bind
multipl
viral
encod
protein
includ
nef
vif
interact
gag
essenti
replic
disrupt
account
antivir
activ
cyclosporin
cyclosporin
interact
directli
viral
protein
therefor
antivir
drug
per
se
prevent
recruit
host
cyclophilin
critic
host
cofactor
author
specul
cyclophilin
could
play
role
transloc
preintegr
complex
could
directli
impact
product
infecti
viru
xray
crystallograph
studi
identifi
solvent
expos
loop
compris
residu
primari
bind
domain
cyclophilin
prolin
tran
conform
result
suggest
cyclophilin
may
facilit
disassembl
capsid
core
incom
virus
structur
perturb
capsid
around
transport
core
cytoplasm
addit
crystallograph
studi
confirm
result
demonstr
bond
primari
recognit
site
cyclophilin
within
expos
loop
residu
constitut
remaind
recognit
motif
biochem
studi
use
well
character
activ
site
mutant
cyclophilin
demonstr
expos
loop
interact
activ
site
cyclophilin
function
signific
expos
loop
demonstr
transfer
capsid
residu
siv
mac
thu
confer
virion
incorpor
cyclophilin
sensit
nonimmunosuppress
analog
cyclosporin
transfer
residu
confer
cyclophilin
incorpor
howev
presenc
cyclosporin
necessari
effici
viral
replic
result
suggest
presenc
absenc
type
ii
tight
turn
adjac
primari
cyclophilin
bind
site
capsid
determin
whether
cyclophilin
enhanc
inhibit
viral
replic
possibl
destabil
capsid
facilit
uncoat
replic
reduc
cyclophilin
ppias
cell
reduct
replic
observ
presenc
cyclosporin
demonstr
cyclophilin
involv
support
replic
replic
rescu
reexpress
cyclophilin
virion
produc
ppias
cell
less
infecti
virion
produc
wild
type
cell
indic
cyclophilin
regul
infect
substitut
cyclophilin
bind
region
capsid
base
lentiviru
vector
correspond
region
macrophag
tropic
bal
resist
restrict
simian
cell
effici
transduc
cell
chimer
viru
requir
cyclophilin
earli
postentri
step
indic
cyclophilin
bind
region
capsid
viral
specif
determin
involv
post
entri
restrict
base
lentiviru
vector
nmr
exchang
spectroscopi
use
demonstr
bond
capsid
bound
cyclophilin
tran
conform
bind
event
exert
distal
effect
region
capsid
although
evid
catalysi
found
catalyt
inact
mutant
cyclophilin
bound
less
tightli
capsid
lead
lower
incorpor
virion
less
infect
indirectli
suggest
isomer
may
enhanc
infect
contribut
process
evid
cyclophilin
mediat
host
cell
restrict
demonstr
show
enhanc
effect
cyclosporin
infect
owl
monkey
cell
observ
cyclosporin
incub
target
cell
occur
regardless
whether
virion
produc
presenc
cyclosporin
result
clearli
indic
function
import
interact
capsid
cyclophilin
occur
owl
monkey
target
cell
complet
independ
effect
viru
produc
cell
mediat
restrict
replic
owl
monkey
cell
reliev
exposur
cyclosporin
wherea
exposur
human
cell
cyclosporin
mutat
cyclophilin
bind
site
expos
loop
capsid
enhanc
recognit
restrict
viral
replic
result
suggest
interact
capsid
cyclophilin
contribut
speciesspecif
restrict
infect
human
recruit
cyclophilin
order
evad
restrict
viral
capsid
also
shown
import
determin
human
restrict
nmlv
infect
soon
viral
entri
host
cell
discoveri
owl
monkey
encod
fusion
protein
provid
immedi
explan
potent
restrict
infect
owl
monkey
could
overcom
presenc
cyclosporin
retrotranspos
cyclophilin
domain
fusion
protein
could
repres
type
adapt
molecular
target
wherebi
function
restrict
direct
specif
incom
viral
capsid
recognit
fuse
cyclophilin
domain
independ
retrotransposit
fuse
cyclophilin
domain
observ
strain
rhesu
macaqu
fusion
protein
restrict
infect
provid
evid
rhesu
owl
monkey
protein
subject
divers
select
pressur
differ
pathogen
virus
variant
restrict
wildtyp
depend
independ
express
cyclophilin
activ
disubstitut
analog
cyclosporin
lack
immunosuppress
properti
shown
correl
ppias
inhibit
vitro
viral
isol
natur
occur
resist
found
resist
correl
presenc
multipl
substitut
capsid
includ
locat
cyclophilin
bind
domain
although
capabl
bind
cyclophilin
revers
genet
demonstr
virus
harbor
chang
cyclophilin
independ
virus
also
capabl
infect
normal
restrict
owl
monkey
cell
indic
capsid
substitut
escap
restrict
fusion
protein
sirna
screen
reveal
express
karyopherin
nucleopor
protein
complex
npc
compon
nucleoporin
import
infect
nondivid
cell
allow
passag
preintegr
complex
npc
deplet
affect
infect
wildtyp
either
presenc
cyclosporin
cell
deplet
cyclophilin
replic
two
well
character
capsid
mutat
also
unaffect
deplet
suggest
motif
within
capsid
determin
util
pathway
import
preintegr
complex
nucleu
nuclear
entri
preintegr
complex
also
shown
util
isotherm
calorimetri
use
demonstr
direct
bind
capsid
cytoplasm
ctermin
cyclophilin
homolog
domain
interestingli
complex
sensit
inhibit
cyclosporin
engag
lead
nuclear
entri
pathway
involv
confer
optim
replic
target
prefer
region
within
genom
integr
presenc
cyclosporin
virus
contain
capsid
mutant
impair
cyclophilin
bind
replic
proce
independ
pathway
less
effici
vitro
studi
indic
transportin
transportin
facilit
infect
coordin
action
cyclophilin
cyclophilin
act
earli
postentri
point
stabil
incom
capsid
possibl
concert
posit
regul
capsid
stabil
includ
pdz
domain
contain
protein
transport
nucleu
capsid
core
encount
cytoplasm
particip
engag
nuclear
pore
complex
acceler
uncoat
therefor
author
postul
cyclophilin
act
posit
neg
regul
uncoat
process
xray
crystallograph
techniqu
use
identifi
uniqu
bind
domain
ntermin
region
capsid
recogn
cleavag
polyadenyl
specif
factor
interestingli
mutat
capsid
confer
independ
nuclear
entri
pathway
longer
capabl
bind
find
suggest
model
wherebi
full
length
recogn
bind
region
ntermin
cyclophilin
bind
domain
capsid
bind
event
facilit
recruit
allow
effici
nuclear
transloc
preintegr
complex
context
repres
host
factor
facilit
infect
nondivid
cell
evid
tight
coupl
process
suggest
find
cyclophilin
homolog
domain
activ
isomeras
implic
role
ppias
catalysi
capsid
uncoat
effici
nuclear
entri
provid
vpxmediat
relief
restrict
replic
demonstr
infect
induc
dendrit
cell
matur
antivir
type
interferon
respons
activ
cell
although
engag
normal
condit
innat
respons
depend
interact
newli
synthes
capsid
cyclophilin
may
function
type
interferon
induc
pathogen
associ
molecular
pattern
macrophag
shown
capabl
detect
infect
activ
antivir
innat
immun
signal
specif
interact
cofactor
suppress
inhibit
mutat
gene
silenc
pharmacolog
intervent
result
suggest
mechan
wherebi
interact
capsid
evad
detect
viral
replic
pathogen
associ
molecular
pattern
receptor
promot
infect
human
mxb
protein
associ
cyclophilin
restrict
infect
cyclophilin
depend
manner
escap
mxb
restrict
associ
alanin
substitut
posit
capsid
cyclophilin
bind
domain
final
clinic
isol
variou
subtyp
exhibit
resist
nonimmunosuppress
cyclosporin
analog
major
natur
occur
polymorph
locat
within
cyclophilin
bind
domain
capsid
mani
also
associ
impair
progress
capsid
core
cytoplasm
incomplet
revers
transcript
lack
transport
preintegr
complex
nuclear
pore
although
understand
precis
mechan
yet
fulli
understood
seem
clear
cyclophilin
interact
major
determin
within
capsid
recognit
multipl
cellular
factor
govern
capsid
core
stabil
uncoat
evas
host
restrict
factor
mask
pathogen
associ
molecular
pattern
receptor
effici
nuclear
transport
preintegr
complex
optim
integr
viral
dna
host
genom
irrespect
exact
mechanist
consider
bind
capsid
repres
highli
conserv
function
cyclophilin
replic
cycl
number
retrovirus
particular
year
ago
report
intracellular
ligand
cyclosporin
involv
replic
nona
nonb
hepat
viru
studi
demonstr
day
intraven
administr
cyclosporin
dose
mgkgday
chronic
infect
chimpanze
associ
improv
liver
histometr
score
author
conclud
cyclosporin
inhibit
prolifer
nona
nonb
hepat
viru
albeit
unknown
mechan
action
author
specul
possibl
separ
immunosuppress
properti
cyclosporin
antivir
activ
may
possibl
clinic
applic
cyclosporin
certain
viral
diseas
involv
immunophilin
replic
cycl
hcv
demonstr
multipl
group
report
describ
vitro
antivir
effect
cyclosporin
differenti
effect
exert
cyclosporin
hcvspecif
rna
replic
implic
cyclophilin
fk
bind
protein
class
immunophilin
whose
express
necessari
order
support
viral
replic
consist
observ
broad
knockdown
cyclophilin
express
suppress
hcv
replic
indic
cyclophilin
primari
target
antivir
activ
cyclosporin
sever
group
report
conflict
result
concern
ident
specif
cyclophilin
isoform
support
hcv
replic
howev
studi
clearli
establish
antihcv
activ
cyclosporin
mediat
cyclophilin
bind
activ
pglycoprotein
bind
activ
activ
nfat
pathway
use
stabl
knockdown
togeth
specif
reexpress
antibodi
neutral
techniqu
cyclophilin
identifi
princip
cyclophilin
requir
support
hcv
replic
furthermor
reexpress
activ
site
mutant
cyclophilin
without
catalyt
activ
rescu
replic
cyclophilin
knock
cell
indic
essenti
role
ppias
catalysi
hcv
replic
result
confirm
use
transgen
mice
express
occludin
knockdown
cyclophilin
express
markedli
inhibit
hcvspecif
rna
replic
provid
first
evid
cyclophilin
genuin
cofactor
support
hcv
replic
vivo
intens
structur
activ
studi
seri
nonimmunosuppress
analog
cyclosporin
establish
correl
inhibit
ppias
catalyt
activ
cyclophilin
inhibit
hcvspecif
rna
replic
genotyp
replicon
studi
led
identif
sever
analog
includ
potenti
candid
clinic
evalu
clinic
antihcv
activ
demonstr
monotherapi
patient
coinfect
chronic
hepat
c
monotherapi
patient
chronic
hepat
c
infect
administr
drug
associ
rapid
profound
reduct
hcvspecif
plasma
rna
absenc
doselimit
toxic
clearli
demonstr
cyclophilin
valid
target
chemotherapeut
intervent
patient
chronic
hepat
c
infect
clinic
develop
compound
extens
review
despit
clinic
success
nonimmunosuppress
cyclophilin
inhibitor
exact
function
cyclophilin
replic
cycl
hcv
antivir
mechan
cyclosporin
nonimmunosuppress
analog
fulli
understood
identifi
discret
role
cyclophilin
hamper
fact
replic
insepar
link
particl
assembl
hcv
replic
cycl
result
analysi
mutat
associ
decreas
sensit
cyclosporin
nonimmunosuppress
analog
use
identifi
biolog
target
infer
potenti
mechanist
role
cyclophilin
sever
possibl
function
suggest
includ
stabil
replic
complex
modifi
rna
bind
capabl
nonstructur
protein
modifi
catalyt
function
nonstructur
protein
rnadepend
rna
polymeras
affect
process
polyprotein
among
possibl
grow
bodi
experiment
evid
indic
protein
primari
biolog
target
cyclophilin
contrast
bond
capsid
protein
repres
primari
bind
determin
cyclophilin
sever
group
shown
multipl
prolin
residu
locat
domain
ii
iii
hcv
protein
serv
bind
determin
cyclophilin
substrat
ppias
catalyt
activ
cyclosporin
nonimmunosuppress
analog
sanglifehrin
analog
abl
disrupt
stabl
complex
form
cyclophilin
dissoci
associ
inhibit
hcv
replic
multipl
mutat
within
domain
ii
requir
order
confer
resist
cyclosporin
identifi
princip
mutat
associ
resist
mutant
protein
contain
substitut
retain
abil
bind
cyclophilin
howev
virus
replic
cyclophilinindepend
manner
introduct
mutat
restor
abil
mutant
virus
harbor
chang
replic
cyclophilin
knockdown
cell
possibl
introduc
conform
flexibl
within
domain
ii
iii
reduc
need
cyclophilin
adepend
isomer
within
region
protein
vitro
mechanist
studi
nonimmunosuppress
cyclophilin
inhibitor
indic
exposur
drug
caus
alter
traffick
within
cell
evidenc
accumul
neutral
lipid
lipid
droplet
decreas
apo
b
secret
vldl
pathway
studi
suggest
cyclophilin
may
import
factor
particl
secret
sinc
virion
assembl
particl
releas
highli
depend
integr
vldl
pathway
increas
attent
focus
observ
hcvspecif
rna
replic
occur
close
associ
intracellular
membran
form
complex
membran
replic
factori
also
refer
membran
web
emerg
result
describ
coordin
function
cyclophilin
complex
hcv
replic
cycl
report
indic
cyclophilin
complex
play
role
rna
synthesi
format
replic
complex
rather
earli
step
preced
format
cyclophilin
inhibitor
includ
cyclosporin
suppress
de
novo
format
doubl
membran
vesicl
highli
characterist
structur
hepacivirus
induc
upon
express
hcv
polyprotein
structur
eman
endoplasm
reticulum
contain
enzymat
activ
replicas
express
alon
promot
format
doubl
membran
vesicl
wherea
express
presenc
suppress
format
suggest
cyclophilin
complex
govern
format
structur
virus
harbor
contain
mutat
abl
gener
doubl
membran
vesicl
cyclophilin
knockdown
cell
consist
prior
observ
indic
substitut
obviat
need
cyclophilin
bind
ppias
catalysi
lead
cyclophilin
independ
phenotyp
taken
togeth
studi
indic
cyclophilin
concert
play
highli
specif
potenti
singular
role
replic
cycl
hcv
regul
biogenesi
membran
web
format
therefor
close
resembl
role
play
cyclophilin
hcv
infect
cyclophilin
appar
play
protect
role
viru
life
cycl
innat
cell
sensor
cyclophilin
bind
capsid
stabil
integr
capsid
core
protect
viral
genom
innat
cell
sensor
recognit
transport
nucleu
migrat
nucleopor
ultim
integr
host
chromosom
figur
top
model
hcv
cyclophilin
bind
trigger
format
doubl
membran
vesicl
serv
compart
viral
rna
replic
occur
shelter
innat
cell
sensor
although
role
cyclophilin
extens
studi
hcv
shown
particip
life
cycl
virus
tabl
summar
particip
cyclophilin
member
variou
viru
life
cycl
report
neutral
cyclophilin
decreas
hbv
replic
specif
either
addit
cyclophilin
inhibitor
cyclosporin
alisporivir
sanglifehrin
deriv
hepatocyt
knock
express
cyclophilin
memberscyclophilin
c
significantli
inhibit
hbv
replic
cyclophilin
assist
hbv
remain
understood
although
studi
propos
interact
cyclophilin
hbv
surfac
antigen
recent
report
suggest
cyclophilin
also
play
import
role
replic
coronavirus
specif
presenc
cyclophilin
inhibitor
cyclosporin
alisporivir
well
suppress
cyclophilin
express
inhibit
human
coronaviru
replic
moreov
low
noncytotox
concentr
cyclosporin
reduc
replic
sever
acut
respiratori
syndrom
coronaviru
sarscov
well
human
coronaviru
hbv
role
cyclophilin
coronaviru
infect
remain
identifi
similarli
silenc
express
cyclophilin
ad
cyclosporin
block
replic
human
cytomegaloviru
wherea
silenc
express
cyclophilin
b
ad
cyclosporin
block
japanes
enceph
viru
jev
replic
cyclophilin
b
also
shown
enhanc
human
papillomaviru
hpv
infect
viral
intern
step
well
anoth
step
downstream
neutral
cyclophilin
cyclosporin
inhibit
replic
serotyp
vesicular
stomat
viru
vsv
conflict
result
describ
role
cyclophilin
influenza
viru
infect
inde
one
studi
liu
et
al
show
knock
cyclophilin
express
enhanc
influenza
viru
replic
protect
protein
degrad
anoth
studi
report
cyclosporin
block
influenza
viru
replic
similar
conflict
result
report
anoth
flaviviru
dengu
viru
one
studi
show
silenc
express
cyclophilin
hepatoma
cell
addit
cyclosporin
inhibit
dengu
replic
howev
two
independ
studi
demonstr
dengu
infect
equal
parent
cyclophilin
knockdown
hepatoma
cell
suggest
dengu
reli
cyclophilin
replic
altogeth
studi
demonstr
member
cyclophilin
famili
control
infect
replic
highli
diverg
virus
includ
current
prime
threat
hcv
hbv
depend
cyclophilin
distinct
virus
variou
step
replic
viral
entri
format
protect
membran
compart
rna
synthesi
multipl
viral
genom
uncoat
nuclear
import
nuclear
entri
emphas
potenti
cyclophilin
inhibitor
therapeut
agent
appar
broadspectrum
cyclophilin
inhibitor
may
suggest
could
exploit
first
line
protect
new
emerg
virus
adenosin
triphosph
immedi
viral
entri
deliveri
viral
capsid
core
cytosol
target
cell
cyclophilin
bind
capsid
core
surround
viral
genom
preserv
stabil
core
transport
nucleu
dock
nucleopor
via
specif
compon
nucleopor
complex
viral
genom
undergo
socal
core
uncoat
allow
passag
viral
genom
nucleopor
integr
host
dna
cyclophilin
inhibitor
bind
enzymat
pocket
cyclophilin
prevent
bind
incom
capsid
core
absenc
cyclophilin
capsid
core
destabil
brake
apart
allow
recognit
viral
genom
cellular
sensor
result
degrad
hcv
entri
viral
rna
decapsid
use
polyprotein
translat
replic
cytoplasm
translat
occur
rough
endoplasm
reticulum
er
produc
singl
polyprotein
cleav
cellular
viral
proteas
produc
structur
nonstructur
protein
ns
replic
posttransl
process
take
place
membran
web
made
ns
host
protein
locat
perinuclear
membran
cyclophilin
bind
membraneanchor
protein
trigger
creation
doubl
membran
vesicl
dmv
new
membran
compart
hcv
rna
occur
protect
manner
presenc
cyclophilin
inhibitor
cyclophilin
unabl
bind
mediat
dmv
unprotect
viral
rna
protein
expos
cellular
sensor
degrad
